M

Metalmark Capital

21 employees

Metalmark Capital is a leading private equity firm established by the principals of Morgan Stanley Capital Partners (MSCP) to manage the

Investor insights

Sectors invested in

Biotechnology4
Health Care3
Pharmaceutical3
Women's Health2
Dermatology2
Medical Device2
Oil and Gas2
Renewable Energy1
Transportation1
Marketing1
Gastroenterology1
Bostwick Laboratories delivers premium laboratory services to hospitals. Bostwick Laboratories’ services include: Urologic Laboratory Services and Subspecialty Laboratory Services1
Medical1
Therapeutics1
Oncology1
Analgesia1
Biopharma1
Diagnostics1
Clinical Development Services1
Rare Disease1

Funding rounds participated in

$30M sweet spot round size

Most of their 14 investments are in rounds between $3.8M and $35M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Buyout
Private Equity
Health Care
Energy
Agribusiness
Industrial
Healthcare
Industrials
Venture Capital

Date founded

2004

Investments made

U

Undisclosed raised $30M on November 7, 2022

Investors: Metalmark Capital

U

Undisclosed raised $35M on November 7, 2022

Investors: Metalmark Capital

U

Undisclosed raised $10M on August 15, 2022

Investors: Metalmark Capital

U

Undisclosed raised undisclosed on January 18, 2022

Investors: Metalmark Capital

J

Jasper Therapeutics raised $100M on September 27, 2021

Investors: Qiming Venture Partners USA, Avego Healthcare Capital, Velan Capital, Kingdon Capital Management, Woodline Partners LP, Apeiron Investment Group and Metalmark Capital

U

Undisclosed raised undisclosed on January 1, 2018

Investors: Metalmark Capital

P

Premier Research raised undisclosed on October 17, 2016

Investors: HarbourVest Partners, Indigo Capital and Metalmark Capital

V

Valagro raised undisclosed on October 14, 2016

Investors: Metalmark Capital

R

Reliance Gathering LLC raised undisclosed on May 23, 2016

Investors: Metalmark Capital

S

Sebela Pharmaceuticals Inc. raised undisclosed on January 1, 2016

Investors: Metalmark Capital

FAQ